| Organism . | Average GC% and protein count . | Pathogenicity/Infections . | Antibiotic resistance genes/enzymes . | Other attributes . | References . |
|---|---|---|---|---|---|
| A. baumannii | 39, 3678 | Ventilator-associated pneumonia, sepsis, UTIs, and skin and soft-tissue infection | MBLs genes of blaOXA-23, blaOXA-40, and blaOXA-58 efflux pumping systems, porins | Degradation of propanil (herbicide) MDR Monophyletic origin Member of ACB complex | Tayabali et al. (2012), Chakravarty 2020, Mea et al. (2021) |
| A. bereziniae | 37.9, 4184 | Bacteremia, especially in immunocompromised patients | blaOXA-58 | Formerly known as Acinetobacter genomospecies 10 MDR species Opportunistic in nature | Favaro et al. (2019), Lee et al. (2020), Reyes et al. (2020) |
| A. calcoaceticus | 38.7, 3592 | Causes pneumonia and other hospital-related infections | blaOXA-822(Class-D) | Cadmium and antibiotic-resistant Reported to be pathogenic in dogs and cat | Obara and Nakae (1991), Glew et al. (1977), Retailliau et al. 1979 |
| A. haemolyticus | 39.5, 3095 | Not mentioned, reported pathogenic | blaOXA-265, blaNDM-1, aphA6, and a resistance-nodulation-cell division-type efflux pump | MDR Can produce phosphate binding exo-biopolymer Aerobic denitrification | Kaur and Ghosh (2015), Bello-López et al. (2019), Bai et al. (2020) |
| A. johnsonii | 41.4, 3291 | Opportunistic pathogen, nematocidal activity against round worm | blaOXA-23 | Degrades naphthalene (NAP) and anthracene (ANT) MDR | Tian et al. (2016), Jiang et al. (2018), Jia et al. (2021) |
| A. junii | 38.7, 3063 | Associated with UTI and outbreaks of sepsis in immuno-compromised patients | Carbapenem resistance, blaOXA-24, and blaOXA-30 | Rarely pathogenic in humans | Abo-Zed (2020), Kollimuttathuillam et al. (2021), Lasarte-Monterrubio et al. (2022) |
| A. nosocomialis | 38.7, 3606 | Pathogenic | blaOXA-24/50 | Member of ACB complex Carbapenem and colistin resistant | Teixeira et al. (2013), Subhadra et al. (2020), Lasarte-Monterrubio et al. (2022) |
| A. pittii | 38.8, 3685 | Causes nosocomial infections, fish pathogenesis reported | blaNDM-1, blaOXA-820, blaADC-43, and aphA6 reported | Member of ACB complex. Carbapenem-resistant phosphate-solubilizing | Iimura et al. (2020), He and Wan (2021) |
| A. seifertii | 38.6, 3651 | Bacteremia | Produces oxa-58, MBLs-2 | Belongs to ACB complex Resistance to levofloxacin and carbapenems, but not colistin | Kishii et al. (2016), Furlan et al. (2019), Na et al. (2021) |
| A. towneri | 41.3, 2614 | Human infections | Plasmid-mediated tet (X3) gene, also produces MBLs-1 | MDR including tigecycline | Ma et al. (2020), Maehana et al. (2021), Wang et al. (2020) |
| A. ursingii | 40.1, 3173 | Blood stream infections | MBLs-producing | Affects immunocompromised and terminally ill patients. Antibiotic resistance | Faccone et al. (2019), Daniel et al. (2021) |
| A. kookii | 43, 2828 | Polyarthritis in giraffe | Unknown | Similar to A. beijerincki Degrades 17α-ethinylestradiol | Schwarz et al. (2020), Palma et al. (2021) |
| A. lwoffii | 42.95, 3100 | Emerging pathogen in fish, causes bacteremia, pneumonia, meningitis, and gastritis in humans | Unknown | Dark-green pigmentation reported | Cao et al. (2018), Kulkarni et al. (2021) |
| A. colistiniresistens | 41.3, 3547 | Blood stream infections | Produces Imp-34- and oxa-58 | Previously known as Acinetobacter genomic species 13BJ/14TU Intrinsic resistance to colistin Carbapenem-resistant | Suzuki et al. (2019), Brasiliense et al. (2021) |
| A. indicus | 45.8, 2733 | Not reported | blaNDM-1 and tet(X) | Biotechnologically significant (lipase and biosurfactant production) Opportunistic pathogen | He et al. (2020), Tang et al. (2021) |
| A. schindleri | 42.5, 2956 | Bacteremia in humans reported | Unknown | Could not use furfural as sole carbon source Opportunistic pathogen | Kee et al. (2018), Mlynarcik et al. (2019), Arteaga et al. (2021) |
| A. radioresistens | 41.8, 2881 | Bacteremia, pneumonia, and hepatic hydrothorax | blaOXA-23-like gene tet(B), aph(3′)-Vla, strA, and strB, | Rarely infects human application in soil bioremediation resistant to ampicillin, ceftriaxone, ceftazidime, cefotaxime, streptomycin, and kanamycin | Arvay et al. (2021), Opazo-Capurro et al. (2019), Liu et al. (2020) |
| Organism . | Average GC% and protein count . | Pathogenicity/Infections . | Antibiotic resistance genes/enzymes . | Other attributes . | References . |
|---|---|---|---|---|---|
| A. baumannii | 39, 3678 | Ventilator-associated pneumonia, sepsis, UTIs, and skin and soft-tissue infection | MBLs genes of blaOXA-23, blaOXA-40, and blaOXA-58 efflux pumping systems, porins | Degradation of propanil (herbicide) MDR Monophyletic origin Member of ACB complex | Tayabali et al. (2012), Chakravarty 2020, Mea et al. (2021) |
| A. bereziniae | 37.9, 4184 | Bacteremia, especially in immunocompromised patients | blaOXA-58 | Formerly known as Acinetobacter genomospecies 10 MDR species Opportunistic in nature | Favaro et al. (2019), Lee et al. (2020), Reyes et al. (2020) |
| A. calcoaceticus | 38.7, 3592 | Causes pneumonia and other hospital-related infections | blaOXA-822(Class-D) | Cadmium and antibiotic-resistant Reported to be pathogenic in dogs and cat | Obara and Nakae (1991), Glew et al. (1977), Retailliau et al. 1979 |
| A. haemolyticus | 39.5, 3095 | Not mentioned, reported pathogenic | blaOXA-265, blaNDM-1, aphA6, and a resistance-nodulation-cell division-type efflux pump | MDR Can produce phosphate binding exo-biopolymer Aerobic denitrification | Kaur and Ghosh (2015), Bello-López et al. (2019), Bai et al. (2020) |
| A. johnsonii | 41.4, 3291 | Opportunistic pathogen, nematocidal activity against round worm | blaOXA-23 | Degrades naphthalene (NAP) and anthracene (ANT) MDR | Tian et al. (2016), Jiang et al. (2018), Jia et al. (2021) |
| A. junii | 38.7, 3063 | Associated with UTI and outbreaks of sepsis in immuno-compromised patients | Carbapenem resistance, blaOXA-24, and blaOXA-30 | Rarely pathogenic in humans | Abo-Zed (2020), Kollimuttathuillam et al. (2021), Lasarte-Monterrubio et al. (2022) |
| A. nosocomialis | 38.7, 3606 | Pathogenic | blaOXA-24/50 | Member of ACB complex Carbapenem and colistin resistant | Teixeira et al. (2013), Subhadra et al. (2020), Lasarte-Monterrubio et al. (2022) |
| A. pittii | 38.8, 3685 | Causes nosocomial infections, fish pathogenesis reported | blaNDM-1, blaOXA-820, blaADC-43, and aphA6 reported | Member of ACB complex. Carbapenem-resistant phosphate-solubilizing | Iimura et al. (2020), He and Wan (2021) |
| A. seifertii | 38.6, 3651 | Bacteremia | Produces oxa-58, MBLs-2 | Belongs to ACB complex Resistance to levofloxacin and carbapenems, but not colistin | Kishii et al. (2016), Furlan et al. (2019), Na et al. (2021) |
| A. towneri | 41.3, 2614 | Human infections | Plasmid-mediated tet (X3) gene, also produces MBLs-1 | MDR including tigecycline | Ma et al. (2020), Maehana et al. (2021), Wang et al. (2020) |
| A. ursingii | 40.1, 3173 | Blood stream infections | MBLs-producing | Affects immunocompromised and terminally ill patients. Antibiotic resistance | Faccone et al. (2019), Daniel et al. (2021) |
| A. kookii | 43, 2828 | Polyarthritis in giraffe | Unknown | Similar to A. beijerincki Degrades 17α-ethinylestradiol | Schwarz et al. (2020), Palma et al. (2021) |
| A. lwoffii | 42.95, 3100 | Emerging pathogen in fish, causes bacteremia, pneumonia, meningitis, and gastritis in humans | Unknown | Dark-green pigmentation reported | Cao et al. (2018), Kulkarni et al. (2021) |
| A. colistiniresistens | 41.3, 3547 | Blood stream infections | Produces Imp-34- and oxa-58 | Previously known as Acinetobacter genomic species 13BJ/14TU Intrinsic resistance to colistin Carbapenem-resistant | Suzuki et al. (2019), Brasiliense et al. (2021) |
| A. indicus | 45.8, 2733 | Not reported | blaNDM-1 and tet(X) | Biotechnologically significant (lipase and biosurfactant production) Opportunistic pathogen | He et al. (2020), Tang et al. (2021) |
| A. schindleri | 42.5, 2956 | Bacteremia in humans reported | Unknown | Could not use furfural as sole carbon source Opportunistic pathogen | Kee et al. (2018), Mlynarcik et al. (2019), Arteaga et al. (2021) |
| A. radioresistens | 41.8, 2881 | Bacteremia, pneumonia, and hepatic hydrothorax | blaOXA-23-like gene tet(B), aph(3′)-Vla, strA, and strB, | Rarely infects human application in soil bioremediation resistant to ampicillin, ceftriaxone, ceftazidime, cefotaxime, streptomycin, and kanamycin | Arvay et al. (2021), Opazo-Capurro et al. (2019), Liu et al. (2020) |
| Organism . | Average GC% and protein count . | Pathogenicity/Infections . | Antibiotic resistance genes/enzymes . | Other attributes . | References . |
|---|---|---|---|---|---|
| A. baumannii | 39, 3678 | Ventilator-associated pneumonia, sepsis, UTIs, and skin and soft-tissue infection | MBLs genes of blaOXA-23, blaOXA-40, and blaOXA-58 efflux pumping systems, porins | Degradation of propanil (herbicide) MDR Monophyletic origin Member of ACB complex | Tayabali et al. (2012), Chakravarty 2020, Mea et al. (2021) |
| A. bereziniae | 37.9, 4184 | Bacteremia, especially in immunocompromised patients | blaOXA-58 | Formerly known as Acinetobacter genomospecies 10 MDR species Opportunistic in nature | Favaro et al. (2019), Lee et al. (2020), Reyes et al. (2020) |
| A. calcoaceticus | 38.7, 3592 | Causes pneumonia and other hospital-related infections | blaOXA-822(Class-D) | Cadmium and antibiotic-resistant Reported to be pathogenic in dogs and cat | Obara and Nakae (1991), Glew et al. (1977), Retailliau et al. 1979 |
| A. haemolyticus | 39.5, 3095 | Not mentioned, reported pathogenic | blaOXA-265, blaNDM-1, aphA6, and a resistance-nodulation-cell division-type efflux pump | MDR Can produce phosphate binding exo-biopolymer Aerobic denitrification | Kaur and Ghosh (2015), Bello-López et al. (2019), Bai et al. (2020) |
| A. johnsonii | 41.4, 3291 | Opportunistic pathogen, nematocidal activity against round worm | blaOXA-23 | Degrades naphthalene (NAP) and anthracene (ANT) MDR | Tian et al. (2016), Jiang et al. (2018), Jia et al. (2021) |
| A. junii | 38.7, 3063 | Associated with UTI and outbreaks of sepsis in immuno-compromised patients | Carbapenem resistance, blaOXA-24, and blaOXA-30 | Rarely pathogenic in humans | Abo-Zed (2020), Kollimuttathuillam et al. (2021), Lasarte-Monterrubio et al. (2022) |
| A. nosocomialis | 38.7, 3606 | Pathogenic | blaOXA-24/50 | Member of ACB complex Carbapenem and colistin resistant | Teixeira et al. (2013), Subhadra et al. (2020), Lasarte-Monterrubio et al. (2022) |
| A. pittii | 38.8, 3685 | Causes nosocomial infections, fish pathogenesis reported | blaNDM-1, blaOXA-820, blaADC-43, and aphA6 reported | Member of ACB complex. Carbapenem-resistant phosphate-solubilizing | Iimura et al. (2020), He and Wan (2021) |
| A. seifertii | 38.6, 3651 | Bacteremia | Produces oxa-58, MBLs-2 | Belongs to ACB complex Resistance to levofloxacin and carbapenems, but not colistin | Kishii et al. (2016), Furlan et al. (2019), Na et al. (2021) |
| A. towneri | 41.3, 2614 | Human infections | Plasmid-mediated tet (X3) gene, also produces MBLs-1 | MDR including tigecycline | Ma et al. (2020), Maehana et al. (2021), Wang et al. (2020) |
| A. ursingii | 40.1, 3173 | Blood stream infections | MBLs-producing | Affects immunocompromised and terminally ill patients. Antibiotic resistance | Faccone et al. (2019), Daniel et al. (2021) |
| A. kookii | 43, 2828 | Polyarthritis in giraffe | Unknown | Similar to A. beijerincki Degrades 17α-ethinylestradiol | Schwarz et al. (2020), Palma et al. (2021) |
| A. lwoffii | 42.95, 3100 | Emerging pathogen in fish, causes bacteremia, pneumonia, meningitis, and gastritis in humans | Unknown | Dark-green pigmentation reported | Cao et al. (2018), Kulkarni et al. (2021) |
| A. colistiniresistens | 41.3, 3547 | Blood stream infections | Produces Imp-34- and oxa-58 | Previously known as Acinetobacter genomic species 13BJ/14TU Intrinsic resistance to colistin Carbapenem-resistant | Suzuki et al. (2019), Brasiliense et al. (2021) |
| A. indicus | 45.8, 2733 | Not reported | blaNDM-1 and tet(X) | Biotechnologically significant (lipase and biosurfactant production) Opportunistic pathogen | He et al. (2020), Tang et al. (2021) |
| A. schindleri | 42.5, 2956 | Bacteremia in humans reported | Unknown | Could not use furfural as sole carbon source Opportunistic pathogen | Kee et al. (2018), Mlynarcik et al. (2019), Arteaga et al. (2021) |
| A. radioresistens | 41.8, 2881 | Bacteremia, pneumonia, and hepatic hydrothorax | blaOXA-23-like gene tet(B), aph(3′)-Vla, strA, and strB, | Rarely infects human application in soil bioremediation resistant to ampicillin, ceftriaxone, ceftazidime, cefotaxime, streptomycin, and kanamycin | Arvay et al. (2021), Opazo-Capurro et al. (2019), Liu et al. (2020) |
| Organism . | Average GC% and protein count . | Pathogenicity/Infections . | Antibiotic resistance genes/enzymes . | Other attributes . | References . |
|---|---|---|---|---|---|
| A. baumannii | 39, 3678 | Ventilator-associated pneumonia, sepsis, UTIs, and skin and soft-tissue infection | MBLs genes of blaOXA-23, blaOXA-40, and blaOXA-58 efflux pumping systems, porins | Degradation of propanil (herbicide) MDR Monophyletic origin Member of ACB complex | Tayabali et al. (2012), Chakravarty 2020, Mea et al. (2021) |
| A. bereziniae | 37.9, 4184 | Bacteremia, especially in immunocompromised patients | blaOXA-58 | Formerly known as Acinetobacter genomospecies 10 MDR species Opportunistic in nature | Favaro et al. (2019), Lee et al. (2020), Reyes et al. (2020) |
| A. calcoaceticus | 38.7, 3592 | Causes pneumonia and other hospital-related infections | blaOXA-822(Class-D) | Cadmium and antibiotic-resistant Reported to be pathogenic in dogs and cat | Obara and Nakae (1991), Glew et al. (1977), Retailliau et al. 1979 |
| A. haemolyticus | 39.5, 3095 | Not mentioned, reported pathogenic | blaOXA-265, blaNDM-1, aphA6, and a resistance-nodulation-cell division-type efflux pump | MDR Can produce phosphate binding exo-biopolymer Aerobic denitrification | Kaur and Ghosh (2015), Bello-López et al. (2019), Bai et al. (2020) |
| A. johnsonii | 41.4, 3291 | Opportunistic pathogen, nematocidal activity against round worm | blaOXA-23 | Degrades naphthalene (NAP) and anthracene (ANT) MDR | Tian et al. (2016), Jiang et al. (2018), Jia et al. (2021) |
| A. junii | 38.7, 3063 | Associated with UTI and outbreaks of sepsis in immuno-compromised patients | Carbapenem resistance, blaOXA-24, and blaOXA-30 | Rarely pathogenic in humans | Abo-Zed (2020), Kollimuttathuillam et al. (2021), Lasarte-Monterrubio et al. (2022) |
| A. nosocomialis | 38.7, 3606 | Pathogenic | blaOXA-24/50 | Member of ACB complex Carbapenem and colistin resistant | Teixeira et al. (2013), Subhadra et al. (2020), Lasarte-Monterrubio et al. (2022) |
| A. pittii | 38.8, 3685 | Causes nosocomial infections, fish pathogenesis reported | blaNDM-1, blaOXA-820, blaADC-43, and aphA6 reported | Member of ACB complex. Carbapenem-resistant phosphate-solubilizing | Iimura et al. (2020), He and Wan (2021) |
| A. seifertii | 38.6, 3651 | Bacteremia | Produces oxa-58, MBLs-2 | Belongs to ACB complex Resistance to levofloxacin and carbapenems, but not colistin | Kishii et al. (2016), Furlan et al. (2019), Na et al. (2021) |
| A. towneri | 41.3, 2614 | Human infections | Plasmid-mediated tet (X3) gene, also produces MBLs-1 | MDR including tigecycline | Ma et al. (2020), Maehana et al. (2021), Wang et al. (2020) |
| A. ursingii | 40.1, 3173 | Blood stream infections | MBLs-producing | Affects immunocompromised and terminally ill patients. Antibiotic resistance | Faccone et al. (2019), Daniel et al. (2021) |
| A. kookii | 43, 2828 | Polyarthritis in giraffe | Unknown | Similar to A. beijerincki Degrades 17α-ethinylestradiol | Schwarz et al. (2020), Palma et al. (2021) |
| A. lwoffii | 42.95, 3100 | Emerging pathogen in fish, causes bacteremia, pneumonia, meningitis, and gastritis in humans | Unknown | Dark-green pigmentation reported | Cao et al. (2018), Kulkarni et al. (2021) |
| A. colistiniresistens | 41.3, 3547 | Blood stream infections | Produces Imp-34- and oxa-58 | Previously known as Acinetobacter genomic species 13BJ/14TU Intrinsic resistance to colistin Carbapenem-resistant | Suzuki et al. (2019), Brasiliense et al. (2021) |
| A. indicus | 45.8, 2733 | Not reported | blaNDM-1 and tet(X) | Biotechnologically significant (lipase and biosurfactant production) Opportunistic pathogen | He et al. (2020), Tang et al. (2021) |
| A. schindleri | 42.5, 2956 | Bacteremia in humans reported | Unknown | Could not use furfural as sole carbon source Opportunistic pathogen | Kee et al. (2018), Mlynarcik et al. (2019), Arteaga et al. (2021) |
| A. radioresistens | 41.8, 2881 | Bacteremia, pneumonia, and hepatic hydrothorax | blaOXA-23-like gene tet(B), aph(3′)-Vla, strA, and strB, | Rarely infects human application in soil bioremediation resistant to ampicillin, ceftriaxone, ceftazidime, cefotaxime, streptomycin, and kanamycin | Arvay et al. (2021), Opazo-Capurro et al. (2019), Liu et al. (2020) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
